PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS

An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, wherein the pharmaceutical composition brings about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention pro...

Full description

Saved in:
Bibliographic Details
Main Authors Baba, Hiroko, Yasuda, Nobuyuki, Mori, Masahiko, Tago, Fumitoshi, Nakano, Tomohisa
Format Patent
LanguageEnglish
French
German
Published 26.04.2017
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, wherein the pharmaceutical composition brings about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention provides a pharmaceutical composition for the treatment of rheumatoid arthritis. The pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient and is used such that at least 100 mg per dose of the anti-fractalkine antibody is subcutaneously administered to a human in need thereof.
Bibliography:Application Number: EP20160194112